Trends

AI-driven sepsis flags, wearable monitors generating false positives, and agentic systems replacing nurse calls—clinical AI is accelerating without sufficient validation.

A national survey of 3,000 U.S. adults reveals that AI performance — not FDA approval or physician oversight — is the single strongest driver of patient trust in medical AI. AI performing at specialist level increased visit selection by 32.5%, a finding with direct implications for how practices deploy and communicate AI tools.

With 4.5 billion people lacking essential healthcare access and an 11 million health worker shortage projected by 2030, artificial intelligence demonstrates measurable impact across diagnostic accuracy, workflow efficiency, and patient triage—yet healthcare remains below average in AI adoption compared to other industries.

A critical analysis of 180,640 patient records reveals that 40% of published AI prediction models use diagnostic codes that aren't finalized until after discharge—achieving artificially inflated accuracy of 97.6% while predending events like "brain death" to predict mortality.

AI-enabled clinical platforms now account for 1.59 million monthly visits—over one-third of traffic compared to traditional resources like UpToDate—yet remain unvalidated for clinical outcomes, raising urgent questions about patient safety and decision-making quality.

Delphi-2M, a generative transformer AI model, accurately predicts rates of over 1,000 diseases up to 20 years in advance by analyzing patient medical histories, demonstrating comparable accuracy to existing single-disease models while providing comprehensive health trajectory forecasting.

UC San Diego researchers used machine learning to identify a 53-gene signature separating inflammatory from tissue-healing macrophages and resolving the decades-long debate over NOD2's role in Crohn's disease.

While 86% of system-affiliated hospitals use predictive AI, only 37% of independent facilities have adopted these tools.

Despite 88% of health systems implementing AI internally, only 17% have established mature governance structures to manage these technologies safely and effectively, according to recent survey data

Google DeepMind's AlphaGenome processes 1 million DNA letters to predict genetic variant effects across 98% of the genome

A recent study reveals significant disparities in AI adoption between hospitals and private practices, highlighting an urgency for AI technologies in private practice.

According to AMA’s 2023 Digital Health Research, nearly 4 in 10 physicians in hospitals report access to AI tools, but only 1 in 10 for small group practitioners